Login / Signup

Ovarian Sertoli-Leydig tumor after bone marrow transplant for sickle cell disease.

Lia Neu PhillipsLakshmanan KrishnamurtiHeather RyttingThomas A Olson
Published in: Pediatric blood & cancer (2018)
As bone marrow transplant for sickle cell disease becomes increasingly common, long-term outcomes including secondary malignancies are beginning to be described. Here, we report a case of ovarian Sertoli-Leydig tumor that occurred after allogeneic bone marrow transplant for sickle cell disease.
Keyphrases
  • sickle cell disease
  • bone marrow
  • mesenchymal stem cells
  • low dose